Complementary use of mpMRI and genomic testing in prostate cancer

Around the Practice | <b>Around the Practice June 23, 2021: Genomic and Genetic Testing in Prostate Cancer</b>

Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses the value of using multiparametric MRI and genomic testing together when making treatment decisions in prostate cancer.

Related Content:

Around the Practice June 23, 2021: Genomic and Genetic Testing in Prostate CancerAround the Practice
Around the Practice July 21, 2021: Bladder Cancer Cases
Genetic, Genomic Testing in Heavily Treated, Metastatic Castrate-Resistant Prostate Cancer
Genetic, Genomic Testing in Newly Diagnosed, High-Grade, High-Risk Prostate Cancer